Latest filing published 03 Jul 2026 for AMOEBA, €26k. Read the official filing
Based on 66 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
All filings by Benoit Villers on record concern Amoeba, in the capacity of board member. Over a trading history stretching from 17 January 2024 to 30 June 2026, the count stands at 68 filings.
Market trades split into 66 purchases (€357k) and 2 sales (€28k). On balance, insiders were net buyers of €329k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. So far in 2026, the count stands at no purchases and 1 sale.
Half of the purchases are above €2,762 and half below. Of 66 purchases, 5 formed part of a group of insiders buying within 30 days of each other. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. Looking at 66 purchases old enough to measure, the stock rose over the following 90 days in 97% of cases; the median change was +23.5%. These figures describe past trades and do not predict future prices.
The latest filing, published on 3 July 2026, reports an open-market sale of €26k in Amoeba. The latest purchase dates back some time: it was published 705 days ago, on 11 November 2024. Typically, a trade is published a median of 2 days after it takes place. Under the Market Abuse Regulation, managers have three business days to notify their trades. Every figure here comes from the filings published by AMF and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 68 declarations